1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Influenza Medication Market  - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025

Influenza Medication Industry: Forecasts to 2025

  • January 2018
  • 159 pages
  • ID: 5309060
In this report:
Figure ##: Sandoz International GmbH (Novartis AG) Breakdown of Net Sales (Overall Company Level), 2016
Figure ##: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales, by Region (Pharmaceutical Segment), 2016
Figure ##: Sun Pharmaceutical Industries Ltd. Breakdown of Net Sales, by Region (overall company), 2016


Table of Contents

Global Influenza Medication Market: Summary

This business report on Influenza Medication Market studies the current as well as future prospects of the market globally. The stakeholders of this report contain firms and intermediaries involved in the manufacture, commercialization, providing services of Influenza Medication Market products including Zanamivir, Oseltamivir, Peramivir, and others as well as additional entrants planning to enter this sector.

This industry report comprises a detailed executive summary together with a market snapshot providing global information of different segments and subsegments considered in the coverage of the report. This section also offers the global information and data analysis of the Global Influenza Medication Market with respect to the leading market segments established on products segment, distribution channels, and geographies.

Global Influenza Medication Market: Key Segments

Established on the product type, the Influenza Medication Market has been split into: Zanamivir, Oseltamivir, Peramivir, Amantadine, Rimantadine, Inosine and Others (laninamivir octanoate, etc.). Each of the market segments have been comprehensively studied based on the market related factors including growing demand of Influenza Medication Market products worldwide, and technological advancement.

Furthermore, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the time span from 2015 to 2025. The study also offers the CAGR for each market segment for the estimate period from 2017 to 2025, considering 2016 as the base year.

Global Influenza Medication Market: Coverage of the study

The section 'market overview' of this report explores the market dynamics including drivers, market restraints, and alternatives that currently have a strong impact on the Influenza Medication Market and could influence the industry in the upcoming future. Analysis of market appeal has been specified in the market survey part in order to explain the intensity of competition in the sector across various areas.

The ambitious scenario among distinct market players is evaluated through market share study in the challenging landscape section of the report. All these aspects would benefit market actors to take tactical decisions in order to enhance their positions and expand their shares in the overall influenza medication market.

Global Influenza Medication Market: Regional Outlook

Geographically, influenza medication market has been divided into five main regions: North America continent, Europe (EU), Asia Pacific (APAC), Latin America area, and Middle East (ME) and African continent. The market value and estimate for each of these regions has been provided for the time span from 2015 to 2025, together with their respective CAGRs for the outlook period from 2017 to 2025, considering 2016 as the base year.

The analysis also provides with market value and estimate for main countries in the respective regions. A in-depth qualitative analysis of factors responsible for driving and restraining the market increase and future opportunities has been specified in the market survey part. This section of the report also provides with Analysis of market appeal, Porter's five forces analysis, and market share review by top players, thus presenting a comprehensive study of the overall competitive scenario in the global Influenza Medication Market.

Companies discussed in the report

The top findings section included in the market research would assist existing market players in expanding their market shares, and additional companies in establishing their presence in the Global Influenza Medication Market. The report also profiles main players operating in the Influenza Medication Market which are Daiichi Sankyo Company, GlaxoSmithKline plc, Natco Pharma, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd. and Mylan, Incorporated.

Global Influenza Medication Market, by Geography

North America (NA)


Canada (CA)

Europe (EU)

Germany (DE)

United Kingdom (UK)

France (FR)

Italy (IT)

Spain (ES)


Rest of the Europe


China (CN)

Japan (JP)

India (IN)

Australia & New Zealand

South Korea (KR)

Rest of Asia Pacific (APAC)

Latin America

Brazil (BR)

Mexico (MX)

Rest of Latin America

African region & Middle East

South africa (SA)

Saudi arabia (SA)

Untied arab emirates (uae)

Rest of African region and Middle East

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2018

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2018

  • $ 3500
  • November 2018

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2018SummaryToll Like Receptor 3 (CD283 or TLR3) pipeline Target constitutes close to 10 molecules. Out of which approximately 8 molecules are ...

Clinical Research in Swine Influenza in H2, 2018

Clinical Research in Swine Influenza in H2, 2018

  • $ 2500
  • August 2018

Swine Influenza Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Swine Influenza Global Clinical Trials Review, H2, 2018" provides an overview of Swine Influenza clinical ...

Haemophilus influenzae Type B Infections R&D Pipeline Analysis Report, H2-2018

Haemophilus influenzae Type B Infections R&D Pipeline Analysis Report, H2-2018

  • $ 2200
  • August 2018

Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studiesHaemophilus influenzae Type B Infections Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive ...


Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on